P4.29_CDA_Papp_PSOLAR_Smoking_v05_FINAL.pptx

First Page		Document Content
Date: 2014-07-30 15:52:40 Monoclonal antibodies Psoriasis Centocor Tobacco Health Ustekinumab Biologic Infliximab Psoriatic arthritis Immunosuppressants Medicine Pharmacology		P4.29_CDA_Papp_PSOLAR_Smoking_v05_FINAL.pptx Add to Reading List Source URL: www.dermatology.ca Download Document from Source Website File Size: 283,88 KB Share Document on Facebook

	September 12, 2018 Japan Tobacco International, USA, Inc. Glenpointe Centre West 500 Frank W. Burr Blvd. #24 Teaneck, NJDear Mr. Jerry Loftin: DocID: 1xVgy - View Document
	Notice to Industry: Additional Tobacco Products Now Regulated by the Food and Drug Administration DocID: 1xVey - View Document
	Tobacco Region Revitalization Commission for the year ended June 30, 2017 DocID: 1xUYe - View Document
	Tobacco industry faces technological disruption Effect on equity and credit for Philip Morris Earnings forecast cut IQOS sales DocID: 1xUsE - View Document
	Illicit Trade in Tobacco Products after Implementation of an FDA Product Standard DocID: 1xTPY - View Document